Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage

Neurocritical Care

Volumn 20, Issue 3, 2014, Pages 382-389

  Schmidt, J Michael ^a   Sow, Daby ^d   Crimmins, Michael ^a   Albers, David ^b   Agarwal, Sachin ^a,b   Claassen, Jan ^a,b   Connolly, E Sander ^b   Elkind, Mitchell S V ^a,c   Hripcsak, George ^b   Mayer, Stephan A ^a,b  

^a Milstein Hospital   (United States)

^b Department of Medicine   (United States)

^c Department of Medicine   (United States)

^d IBM T J WATSON RESEARCH CENTER   (United States)

Author keywords

Cerebral vasospasm; Delayed cerebral ischemia; Heart rate variability; Nosocomial infection; Sepsis; Subarachnoid hemorrhage

Indexed keywords

ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPERTENSIVE FACTOR; NIMODIPINE; PROPOFOL; SEDATIVE AGENT;

ADULT; ALGORITHM; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED CEREBRAL ISCHEMIA; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RR INTERVAL; SECONDARY COMPLICATION; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; APACHE; COMPUTER PROGRAM; CROSS INFECTION; HEART RATE; INTENSIVE CARE; MIDDLE AGED; RISK FACTOR; SEPSIS;

ALGORITHMS; APACHE; CROSS INFECTION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SOFTWARE; SUBARACHNOID HEMORRHAGE;

EID: 84902362707     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-014-9966-y     Document Type: Article

References (28)

1. Qureshi AI, Suri MF, Nasar A, et al. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery. 2005;57:1-8 (discussion 1-8).
2. Diringer MN. Management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2009;37:432.
3. Moorman JR, Carlo WA, Kattwinkel J, et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr. 2011. doi:10.1016/j.jpeds.2011.06.044.
4. Ahmad S, Ramsay T, Huebsch L, et al. Continuous multiparameter heart rate variability analysis heralds onset of sepsis in adults. PLoS One. 2009;4:e6642.
5. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000;26:S064-74.
6. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Investig. 2007;117:289-96. (Pubitemid 46203953)
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250-6. (Pubitemid 36444440)
8. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38:1336-45. (Pubitemid 350192404)
9. Provencio JJ, Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol. 2005;25:435-44.
10. Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8:404-12.
11. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32:1989-93. (Pubitemid 32868085)
12. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123-33 (discussion 33-5).
13. Wartenberg KE, Schmidt JM, Temes RE, et al. Medical complications after subarachnoid hemorrhage: frequency and impact on outcome. Stroke. 2005;36:521.
14. Park S, Kaffashi F, Loparo KA, Jacono FJ. The use of heart rate variability for the early detection of treatable complications after aneurysmal subarachnoid hemorrhage. J Clin Monit Comput. 2013;27:385-93.
15. Akbani R, Kwek S, Japkowicz N. Applying support vector machines to imbalanced datasets. Machine Learning: ECML 2004. Berlin: Springer; 2004. p. 39-50.
16. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
17. Komotar RJ, Schmidt JM, Starke RM, et al. Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery. 2009;64:397-411.
18. Hamilton PS, Tompkins WJ. Quantitative investigation of QRS detection rules using the MIT/BIH arrhythmia database. IEEE Trans Biomed Eng. 1986;33:1157-65.
19. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
20. Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10:88-101. (Pubitemid 40476672)
21. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation. 1998;98:547-55. (Pubitemid 28371253)
22. Campbell B, Sturani A, Reid J. Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci. 1985;68:49-56. (Pubitemid 15177949)
23. Stein PK, Schmieg RE Jr, El-Fouly A, Domitrovich PP, Buchman TG. Association between heart rate variability recorded on postoperative day 1 and length of stay in abdominal aortic surgery patients. Crit Care Med. 2001;29:1738-43. (Pubitemid 32848374)
24. Electrophysiology, Task Force of the European Society of Cardiology the North American Society of Pacing. Heart rate variability : standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-65.
25. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617-23 (quiz 24).
26. Rothoerl RD, Axmann C, Pina AL, Woertgen C, Brawanski A. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2006;18:68-72. (Pubitemid 44491162)
27. Kubo Y, Ogasawara K, Kakino S, et al. Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage. Surg Neurol. 2008;69:592-6 (discussion 6).
28. Badjatia N, Carpenter A, Fernandez L, et al. Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2011;42:2436-42.